Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Dual inhibitors of HER1/HER2 presented at ACS meeting by Bristol-Myers Squibb

Sep. 9, 2003

Small molecule selectively targeting HER2 selected for development by Pfizer

Sep. 9, 2003

Valera adopted as new name for Hydro Med Sciences

Sep. 9, 2003

Biphenyl-based antiandrogenic agents covered by Endorecherche patent

Sep. 9, 2003

Novel GnRH modulators prepared and tested by Pfizer researchers

Sep. 9, 2003

GW-572016, a dual EGFR/ErbB-2 TK inhibitor, discussed in ACS presentation

Sep. 8, 2003

Bicyclic androgen receptor antagonists pursued at BMS

Sep. 8, 2003

Japanese group identifies new antiangiogenic/antimetastatic MMP inhibitor

Sep. 8, 2003

Micromet to develop CAT's EpCAM-targeting antibody

Sep. 8, 2003

Two new phase I trials investigate Xcytrin plus Taxotere for advanced cancers

Sep. 8, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Reunion Neuroscience reports new 5-HT2A partial agonists and/or 5-HT2B antagonists
BioWorld Science
Reunion Neuroscience Inc. has identified new 5-HT2A receptor partial agonists and/or 5-HT2B receptor antagonists potentially useful for the treatment of...